Kidney And Liver Cancer Drug Raises High Blood Pressure Risk
Written by Catharine Paddock
Sorafenib, a new anti tumour (antineoplastic) drug marketed by Bayer under the brand Nexavar, and used to treat patients with advanced kidney or liver cancer, has been found to increase significantly the risk of developing high blood pressure...[read article]
Beyond The Abstract - Pathological Evidence Of Necrosis In Recurrent Renal Mass Following Treatment With Sunitinib
Low Dose Computed Tomography For The Evaluation Of Flank Pain In The Pregnant Population
Recipient Got Wrong Donor Kidney And Had To Have It Removed
Kidney Cysts: Not All Created Equal
Beyond The Abstract - Sequential Bilateral Minimum Incision Endoscopic Radical Nephrectomy In Dialysis Patients With Bilateral Renal Cell Carcinomas
Beyond The Abstract - The Value Of Combined Use Of Survivin, Cytokeratin 20 And Mucin 7 MRNA For Bladder Cancer Detection In Voided Urine
Overlap Of Voiding Symptoms, Storage Symptoms And Pain In Men And Women
Saturday, January 26, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment